Theraclion Reports Voting Rights and Share Capital Information

Theraclion, a MedTech company based in Malakoff, France, has disclosed its monthly update on the total number of voting rights and shares comprising its share capital. As of July 31, 2026, the number of shares of Theraclion stands at 73,543,457. The theoretical voting rights total 88,767,504, while the actual voting rights, which can be exercised at the Annual General Meeting, amount to 86,957,843. These figures are calculated according to Article 223-16 of the AMF's General Regulation.

Theraclion is listed on Euronext Growth Paris and is eligible for the PEA-PME scheme, enhancing its attractiveness to investors. The company's ISIN code is FR0010120402. These updates reflect transparency in corporate governance and provide stakeholders with essential information regarding shareholder influence.